- Wholesaler purchases rose to 792 units in Q4 from 360 in Q3 (+120% QoQ).
- 54 institutions have ordered LYMPHIR to date, up from 44 in mid-August.
- Preliminary commercial update issued via Item 2.02 by majority-owner Citius Pharma.
?? Positive AI Sentiment (+4.5 / 10)
Observed market reaction after signal
Peak +1.98%